RecruitingNCT07297394

Mechanisms of Maternal Immune Tolerance in Early Pregnancy


Sponsor

University Hospital, Basel, Switzerland

Enrollment

100 participants

Start Date

Mar 2, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study explores the mechanisms of maternal immune tolerance in early pregnancy by characterizing immune cell profiles and functional pathways during the first trimester. The goal is to identify immunological factors that support healthy gestation and prevent complications such as miscarriages.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood sampling for people with immune tolerance, in-vitro fertilization, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood sampling

Blood samples will be analyzed before and during early pregnancy as well as after early miscarriage


Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07297394


Related Trials